Very scary!!

I guess the comments re the antidote for Eliquis (cost and need for facility proximity) must be the same for Xarelto and all the oral blood thinners.

I must check this out. If this is true (re unavailability of antidote) I certainly think that would outweigh the stroke avoidant advantages of the blood thinner.
15% of strokes after all are hemorrhagic , besides which with age, fall risk increases (and hence head injuries).

I certainly think any responsible cardiologist should take this cost/benefit into consideration when prescribing an AFIB patient with a blood thinner!